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Abstract
Glioma-initiating cells (GICs) represent a potential important
therapeutic target because they are likely to account for the frequent
recurrence of malignant gliomas; however, their identity remains
unsolved. Here, we characterized the cellular lineage ﬁngerprint of
GICs through a combination of electrophysiology, lineage marker
expression, and differentiation assays of 5 human patient-derived
primary GIC lines. Most GICs coexpressed nestin, NG2 proteogly-
can, platelet-derived growth factor receptor->, and glial ﬁbrillary
acidic protein. Glioma-initiating cells could be partially differentiated
into astrocytic but not oligodendroglial or neural lineages. We also
demonstrate that GICs have a characteristic electrophysiologic pro-
ﬁle distinct from that of well-characterized tumor bulk cells. To-
gether, our results suggest that GICs represent a unique type of cells
reminiscent of an immature phenotype that closely resembles but is
not identical to NG2 glia with respect to marker expression and
functional membrane properties.
Key Words: Glioblastoma, Glioma-initiating cells, Nestin, NG2,
Patch clamp.
INTRODUCTION
Malignant gliomas are the most frequent and malignant
primary brain tumors in adults (1). Despite aggressive multi-
modal therapies consisting of surgical resection, radiotherapy,
and chemotherapy with temozolomide (2), the median sur-
vival in glioblastoma multiforme (GBM), the most common
malignant glioma, is less than 15 months (2). This is in part
caused by the remarkable invasive potential of GBM, which
makes complete resection unfeasible (3). Therefore, devel-
opment of more effective therapies will require the ablation of
the cellular population that retains the ability to proliferate and
invade after current therapeutic strategies. However, the exact
identity (and even the mere existence) of such cell type re-
mains disputed (4).
Transgenic mouse models and gene transfer technolo-
gies have provided substantial information on the potential
roles of several CNS cell types in the genesis of gliomas (5).
Mutations in astrocytes (6), neural stem cells (NSCs) (7), and
oligodendrocyte progenitor cells (OPCs) (8, 9) can all induce
gliomagenesis, indicating that the ability to give rise to primary
tumors may not be restricted to a single cell type; however,
the extent to which the cell of origin in mouse models re-
capitulates the diverse cellular composition of human late-stage
tumors remains unknown (5, 10, 11).
Markers characteristic of normal NSCs and progenitor
cells, notably nestin (12), glial ﬁbrillary acidic protein (GFAP)
(13), and chondroitin sulfate proteoglycan (NG2) (14, 15) have
all been demonstrated in biopsies of human GBM. Further-
more, distinct subpopulations of human glioma cells that share
common characteristics with NSC/progenitors have been iso-
lated from human neoplasms (16, 17). These populations,
termed ‘‘glioma stem cells’’ or ‘‘glioma-initiating cells’’ (GICs),
are characterized by the expression of NSC markers and, re-
markably, by the ability to differentiate and initiate tumors
that recapitulate the hallmark characteristics of the source tu-
mor (17Y19). Nevertheless, the cellular origin of GICs re-
mains poorly understood (5, 20). The expression of markers
of NSC/progenitor cells in GICs is not unequivocal evidence
for an origin in transformed NSC/progenitor cells (21) be-
cause, under pathologic conditions, certain marker proteins
might confer a selective advantage for glioma cells in the
tumor microenvironment and thus not faithfully represent
lineage (22).
Novel approaches are therefore needed to gain insight
into the identity of GICs. The cellular populations of the
normal brain have been thoroughly characterized based on
their membrane properties, which represent an electrophysi-
ologic signature of lineage (23Y28). The robustness of this
ﬁngerprint relies on the high resolution of the patch clamp
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technique, which allows the measurement of the functional
features of an ensemble of molecules in real time (29). This
approach has successfully been applied to glioma cells (30, 31)
and has allowed the identiﬁcation of several types of ion chan-
nels in primary cells and tumor slices such as Ca2+-activated
(31Y34) and inwardly rectifying K+ channels (35, 36), chloride
channels (37), Ca2+-permeable channels (38, 39), and Na+
channels (40). However, it is unknown if the electrophysio-
logic proﬁle of GBM cells from the bulk of the tumor retains
that of GICs.
In this study, we combined functional membrane prop-
erty measurements of human GICs with lineage marker deter-
mination and differentiation potential. We describe for the ﬁrst
time the membrane properties of GICs and show that they
possess a distinct phenotype reminiscent of an immature pop-
ulation and closely resemble NG2 glia with respect to lineage
marker expression and electrophysiologic proﬁle. Further-
more, we provide evidence for a cell typeYspeciﬁc ion-channel
ensemble that is different from all previously described cell
populations in the CNS, thereby presenting an alternative
class of membrane-associated target molecules for potential
anti-GIC therapies.
MATERIALS AND METHODS
Biopsy Collection and Glioma Sphere Culture
Human glioma sphere cultures were established from
GBM specimens obtained at the University Medical Center
Go¨ttingen in accordance with the University Medical Center
Go¨ttingen Ethical Review Board. Tumors were character-
ized histologically according to the 2007 World Health
Organization Classiﬁcation of Tumors of the Central Ner-
vous System (41) (Figure, Supplemental Digital Content 1,
http://links.lww.com/NEN/A436 shows hematoxylin and eosinY
stained human GBM biopsies). Tumor tissue was dissociated
using the Neural Dissociation Kit (Miltenyi Biotech, Teterow,
Germany), according to the manufacturer’s recommenda-
tions. Serum-free culture medium consisted of NeuroBasal
medium supplemented with B27 supplement (Invitrogen,
Darmstadt, Germany), 10 ng/mL ﬁbroblast growth factor 2,
and 20 ng/mL epidermal growth factor (both from R&D
Systems, Abingdon, UK).
The tumorigenic potential of the cell lines was tested
by orthotopic implantation in immunodeﬁcient mice. All
lines used in this study produced tumors with morphologic
features of GBM (Figure, Supplemental Digital Content 1,
http://links.lww.com/NEN/A436).
Cell Culture
The melanoma cell line B16-V was obtained from the
German Collection of Microorganisms and Cell Cultures
(DSMZ, Braunschweig, Germany). The cells were main-
tained in RPMI 1640 medium (Gibco, Darmstadt, Germany)
supplemented with 10% fetal calf serum ([FCS] Gibco) at
37-C and 5% CO2 in a humidiﬁed atmosphere. The medium
was replaced every 2 to 3 days. The cells were subcultured
when 60% to 80% conﬂuence was reached. Primary mouse
hippocampal cultures were prepared as previously described
(42). Primary mouse astrocyte cultures and primary mouse
oligodendrocyte progenitors were kind gifts from G.M.
Kuscher and Dr. N. Manrique-Hoyos and S. Schmitt, re-
spectively (Max-Planck-Institute of Experimental Medicine,
Go¨ttingen, Germany).
Electrophysiology
Dissociated glioma spheres were plated on poly-l-lysineY
coated coverslips for 24 to 48 hours before recording. Bath so-
lution contained 140 mmol/L NaCl, 1.8 mmol/L KCl, 2 mmol/L
MgCl2, 2 mmol/L CaCl2, 10 mmol/L HEPES (pH 7.3). Alter-
natively, for experiments in which the extracellular K+ concen-
tration was 130 mmol/L, the bath solution contained 10 mmol/L
NaCl, 130 mmol/L KCl, 2 mmol/L MgCl2, 2 mmol/L CaCl2,
10 mmol/L HEPES, T 10 Kmol/L Ba2+ (when indicated)
(pH 7.3). Patch pipettes had 3 to 5 M6 resistance. Intracel-
lular solution contained 130 mmol/L KCl, 10 mmol/L NaCl,
2 mmol/L MgCl2, 2 mmol/L CaCl2, 10 mmol/L EGTA, and
10 mmol/L HEPES (pH 7.3). In experiments where 0 MgCl2
intracellular solution was used, EGTA was replaced with
HEDTA. Currents were recorded using an EPC9 ampliﬁer
(HEKA Elektronik, Lambrecht, Germany). After achieving
whole-cell conﬁguration, cell capacity and series resistance
were determined using the Cslow compensation feature of the
ampliﬁer. Cells with series resistance more than 8 M6 be-
fore compensation were discarded. Series resistance was
compensated to 70% to 80% and readjusted before each
sweep. For current clamp experiments, series resistance was
controlled in voltage clamp mode before and after stimula-
tion. Cells were discarded if series resistance changes were
more than 20% throughout the experiment. Unless otherwise
stated, holding potential was j80 mV. Tetraethylammonium
chloride (TEA), tetrodotoxin (TTX), >-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA), and cyclothiazide
(CTZ) were applied through an external perfusion system
(Nanion, Munich, Germany). All toxins and chemicals were
from Sigma-Aldrich (Munich, Germany). Stimulus and data
acquisition were controlled using Pulse software (HEKA
Elektronik). Data analysis was performed using IgorPro (Wave-
metrics, Lake Oswego, OR), PulseFit (HEKA Elektronic), and
Prism (GraphPad Software, La Jolla, CA).
To determine the extent of gap junctional communica-
tion, dissociated glioma spheres were cultured at conﬂuence,
and 1% Lucifer yellow (Invitrogen) in intracellular solution was
injected through the patch pipette; dye coupling was followed
for 30 minutes. Three images were acquired in 10-minute in-
tervals using a Moticam 1000 digital camera and the Motic
Images Plus software (Motic, Wetzlar, Germany).
Immunocytochemistry and Immunoblotting
Cells were plated on poly-l-lysineYcoated (dissociated
glioma spheroids and adherent cultures) or uncoated glass
coverslips (primary astrocyte and mouse hippocampal cul-
tures) and immunostained as previously described (42). TO-
PRO-3 (Invitrogen) was used to counterstain cell nuclei. The
following primary antibodies and the corresponding dilutions
were used: anti-GFAP 1:100 (Cell Signaling Technology,
Danvers, MA; Promega, Mannheim, Germany), antiYmyelin
basic protein ([MBP] 1:1000; Covance, Munich, Germany),
anti-GluR1 (1:250; Synaptic Systems, Go¨ttingen, Germany),
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antiYplatelet-derived growth factor-> ([PDGFR->] 1:250;
Santa Cruz Biotechnology, Santa Cruz, CA), O4 1:200
(R&D Systems), ELAVL2-4 1:500 (Abcam, Cambridge,
UK); and from Millipore (Darmstadt, Germany): anti-NG2
(1:500), anti-NeuN (1:1000), and anti-nestin (1:1000). Fluo-
rescence signals were collected with an LSM 510 Meta con-
focal microscope (Carl Zeiss, Jena, Germany) using 40 or
63 oil immersion objectives. For Western blotting, primary
antibodies against nestin and NG2 were used at 1:1000 dilu-
tion. An anti-calnexin antibody (1:2000; Enzo Life Sciences,
Lo¨rrach, Germany) or anti-actin antibody (1:3000; Abcam)
were used as loading controls.
Real-time Polymerase Chain Reaction
Total RNA obtained from cultures using RNeasy mini
kit (Qiagen, Hilden, Germany) was reverse transcribed (Super-
Script; Invitrogen, Karlsruhe, Germany) with oligo-dT. Primers
were designed using the Universal Probe Library (UPL) assay
design center (Roche, Mannheim, Germany). Real-time po-
lymerase chain reaction (PCR) was performed on the template
using the UPL system (Roche) in a LightCycler 480 (Roche).
Human actin and the human transferrin receptor were used as
a control template for RNA integrity and PCR performance.
Relative quantiﬁcation was performed using the REST soft-
ware (Relative Expression Software Tool) (43, 44). Gene names
and their corresponding reference sequences, speciﬁc primers,
and UPL probes are listed in Table, Supplemental Digital
Content 2, http://links.lww.com/NEN/A437.
Differentiation Assays
Cells plated on glass coverslips in neurobasal medi-
um were allowed to adhere overnight. Growth factors were
then removed or medium was supplemented with 10%
FCS, 100 ng/mL ciliary neurotrophic factor (CNTF), or 10
Kmol/L forskolin (both from Sigma-Aldrich, Munich, Ger-
many). Alternatively, modiﬁed SATO medium (mSATO)
containing l-tyroxine and triiodothyroxine (Millipore), as
described in Fitzner et al (45), was used. Cultures were
analyzed 3 to 7 days later.
Flow Cytometry
Single-cell suspensions were stained with mouse mono-
clonal anti-human NG2/MCSP-phycoerythrinYcoupled anti-
body (R&D Systems) according to the manufacturer’s protocol
and further incubated with TO-PRO-3 for 5 minutes to docu-
ment membrane integrity and analyzed in a FACSAria ﬂow
cytometer (BD Biosciences, Heidelberg, Germany). Fluores-
cence emission was collected using 576/26 and 660/20 ﬁlters
for phycoerythrin and TO-PRO-3, respectively. Linear forward
and side scatter and TO-PRO-3 gates were used to identify
single viable cells, and at least 104 events were recorded. Data
processing was done with FlowJo v7.5 software (Tree Star,
Ashland, OR).
Statistical Analysis
Data were analyzed using Prism or IgorPro. Student
t-test, W2, or one-way analysis of variance (ANOVA) with
FIGURE 1. Chondroitin sulfate proteoglycan (NG2) and nestin are widely expressed in dissociated glioma spheroids. (A) Repre-
sentative Western blots showing expression of NG2 (upper panel) and nestin (lower panel) in glioma-initiating cell (GIC) lines. Total
mouse brain lysates (brain), B-16 mouse melanoma cell line (B-16), and total mouse liver lysates were used as controls for NG2. For
nestin, U251 glioma cells and total mouse brain were used as positive and negative controls, respectively. (B) Flow cytometry
indicates the membrane expression of NG2 (red) in more than 84% of the cells in all GIC lines. Black, unlabeled controls. B16 cells
were used as a negative control. AU, arbitrary units.
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post hoc Tukey or Dunnett method was used as appropri-
ate. Unless otherwise stated, all data are reported as mean T
SEM. Asterisks indicate p G 0.05 (*), p G 0.01 (**), and
p G 0.001 (***).
RESULTS
GIC Lines Express Markers of Neural Stem and
Progenitor Cells
NG2 expression was determined by Western blot. We
detected a band of the expected size (È280 kDa) in all lines
tested (n = 5) (Fig. 1A). Then, we measured the percentage of
positive cells for membrane-associated NG2 by ﬂow cytom-
etry. We detected a single population with a shift in the ﬂuo-
rescence intensity of 1 to 2 orders of magnitude in all cell lines
(Fig. 1B). At least 80% of the cells showed signals above
background. No changes in ﬂuorescence intensity were de-
tected in B16, an NG2-negative mouse melanoma line (46).
We next determined the subcellular localization of NG2
in glioma cells by immunocytochemistry. NG2 signal was
localized in a nonuniform fashion to the cell membrane.
In No. 10 and No. 1034, there was strong overall staining of
the membrane, with an accumulation in some cell processes.
For No. 1063, No. 1095, and No. 1051, localized expression in
processes was predominant and was accompanied by weaker
and nonhomogeneous staining of the cell membrane (Fig. 2).
Because NG2 is a known marker of OPC/NG2 glia,
we tested the expression of another OPC-speciﬁc marker,
PDGFR-> (47). All NG2-positive cells analyzed expressed
PDGFR-> (No. 10, n = 141; No. 1034, n = 52; No. 1051, n = 34;
No. 1063, n = 30; No. 1095, n = 25). Very few cells (G2%)
expressed PDGFR-> without evident NG2 expression.
We then tested whether nestin, a protein often found in
progenitors and GICs (20), was also expressed in the lines. A
band of approximately 230 kDa, compatible with the molec-
ular weight of nestin, was detected by Western blot in all lines
(Fig. 1A); by immunocytochemistry, there was a strong signal
in approximately 98% of the cells. Both proteins colocalized
to the same cells; double labeling with anti-NG2 and anti-
nestin antibodies conﬁrmed that a vast majority of cells were
NG2 positive/nestin positive (Fig. 2).
Unlike NG2 and nestin, GFAP expression was variable
across lines. Numbers 10 and 1034 had a subpopulation with
marked GFAP expression (41% T 8% and 31% T 2% cells,
respectively), whereas cell lines 1063, 1095, and 1051 were
nearly negative (Fig. 3A). No reactivity was observed for
O4, MBP, ELAVL2-4, or NeuN in any of the lines.
FIGURE 2. Immunoﬂuorescence images of glioma-initiating cells labeled with antiYchondroitin sulfate proteoglycan (NG2) (green)
and anti-nestin (red) antibodies. Number 1034 is enlarged to illustrate structural details (top row). TO-PRO-3 (TP3) was used as a
nuclear marker (blue). Scale bar = 20 Km.
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FIGURE 3. The differentiation potential of glioma-initiating cells (GICs) is restricted to the astroglial lineage. (A) Percentage of
glioma cells with marked glial ﬁbrillary acidic protein (GFAP) expression (GFAP+) in response to distinct differentiation stimuli:
modiﬁed SATO medium (mSATO), ciliary neurotrophic factor (CNTF), forskolin (FORS), or fetal calf serum (FCS). Cells grown in
neurobasal medium (NB) were used as a control (one-way ANOVA with Dunnet test, n Q 3 independent experiments). (B) Glial
ﬁbrillary acidic protein immunoﬂuorescence of GICs. Glial ﬁbrillary acidic protein expression increases, and the morphology
changes in response to FCS (middle row) and on growth factor removal (lower row) as compared with the control condition (NB,
upper row). Scale bar = 40 Km.
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GICs Show Preferential Astroglial Differentiation
A central feature that NSCs and OPCs share with GICs
is their ability to produce a phenotypically heterogeneous
lineage (10, 17, 20). The lineage of a cell’s progeny can also
shed light on the identity of a progenitor cell. To determine
the differentiation capacity, we assessed the expression of
markers of astroglial, oligodendroglial, and neuronal lineages
in neurosphere-forming glioma cells under experimental
conditions known to induce differentiation in normal NSCs
and OPCs.
The addition of 10% FCS produced a signiﬁcant incre-
ment in the percentage of cells with marked GFAP expres-
sion. The increase was in the range of 30% to 50% for those
cell lines with initial heterogeneous GFAP expression (No. 10
and No. 1034) and between 15% and up to 63% in those cell
lines with low or absent basal GFAP expression (No. 1063,
No. 1095, and No. 1051) (Fig. 3A). The response to FCS was
observed in all lines and was also characterized by morpho-
logic changes, that is, the appearance of multiple cellular
processes (Fig. 3B). A more dramatic effect was observed on
growth factor removal, where intense GFAP expression was
detected in practically all cells across lines and was accom-
panied by marked morphologic changes (Fig. 3B). Remark-
ably, GICs showed no expression of the late neuronal marker
NeuN or oligodendroglial markers O4 and MBP in response
to these treatments, suggesting a propensity toward an astro-
glial differentiation. Interestingly, in cell lines 1095 and 1051,
a small percentage of cells (G5%) expressed the early neuronal
marker ELAVL2-4 after 7 days of growth factor removal. To
test the apparent incompetence of GICs to produce mature
neurons or differentiate along the oligodendroglial lineage,
we used more speciﬁc differentiation regimens. To this end,
the lines were grown in the presence of CNTF, mSATO, or
forskolin to promote differentiation into the oligodendroglial
(45, 48) or neuronal (9) lineage, respectively.
Contrary to control OPCs, GICs did not differentiate
along the oligodendroglial lineage in any of the treatments,
as evidenced by a lack of MBP or the early marker O4 (data
not shown). Instead, an increment in the percentage of cells
with markedly enhanced GFAP expression was observed
in those lines with low basal GFAP levels (8% in No. 1063,
p = 0.03; 2.1% in No. 1051, p = 0.01; and 71% in No. 1095,
p G 0.0001), similar to the response observed on growth factor
removal and 10% FCS (Fig. 3A). In No. 1095, the increase
was even more pronounced under mSATO than with 10%
FCS. Cell line 10 also showed a tendency to an increase in
GFAP-expressing cells on exposure to mSATO or CNTF.
A similar effect was observed in No. 1034 in response to
mSATO and No. 1051 in response to CNTF (Fig. 3A). No
NeuN expression could be detected after 7 days with forskolin,
and, as with the treatment with growth factor removal, only a
small proportion of cells showed ELAVL2-4 expression after
forskolin treatment in No. 1095 and No. 1051 (Figure, Sup-
plemental Digital Content 3, http://links.lww.com/NEN/A438).
A signiﬁcant increase in GFAP-expressing cells was again
observed in all lines, although only marginally in No. 1051
(Fig. 3A).
GICs Have Reduced Expression of Connexins and
Exhibit No Dye Coupling
Concomitant expression of NG2, PDGFR->, nestin, and
GFAP and a differentiation potential preferentially oriented
toward an astroglial lineage do not conform to the description
of any CNS subpopulation. Therefore, we wanted to know
whether glioma cells exhibit functional features attributed to
normal NSCs, NG2 glia, or rather of terminally differentiated
glial populations.
A distinctive feature of normal CNS subpopulations is
the extent of gap junctional communication, a type of intercel-
lular communication mediated by gap junctional channels that
are formed by the docking of hemichannels from adjacent cells.
The channel proteins encoded by the connexin genes exhibit
preferential lineage expression. For example, connexin 30
(Cx30) and Cx43 represent typical astroglial connexins, whereas
Cx47, Cx32, and Cx29 are mainly present in oligodendrocytes
(49). Therefore, we determined the relative RNA expression of
these connexins in GICs compared with human brain total RNA
by real-time PCR. Interestingly, GICs expressed both the oli-
godendroglial Cx29 and the astroglial Cx43 but at signiﬁcantly
reduced levels (G43% and 34%, respectively) compared with
human brain (Fig. 4A). Moreover, in some cell lines (No. 1063
and No. 1051), the relative expression of Cx43 was dramatically
reduced (6% and G1%, respectively), and for Cx29 in No. 1034
and No. 1051, the levels were approximately 10%. Other oligo-
and astroglial connexins (Cx47, Cx32, and Cx30) were unde-
tectable (data not shown).
Given the preferential astrocytic differentiation of GICs,
we tested whether the reduced expression of Cx43 at the RNA
level was reﬂected at the protein level by performing Western
blot. We detected a faint band at the expected molecular
weight (È43 kDa) for Cx43 in most GICs; no band was ob-
served for No. 1051 (Fig. 4B).
Additional evidence for the degree of gap junctional
communication was obtained at a functional level by mea-
suring the extent of cell-to-cell transfer of ﬂuorescent dye
(dye coupling). NG2 glial cells ﬁlled with ﬂuorescent dyes
show no communication with neighboring cells (25, 50),
whereas astrocytes exhibit extensive intercellular connection
FIGURE 4. Glioma-initiating cells (GICs) have reduced expression of connexins and no dye coupling. (A) Normalized expression of
connexin 29 (Cx29) (upper panel) and Cx43 RNA (lower panel) showing a signiﬁcant relative reduction compared with that of
human brain. (B) Upper panel: Western blot for Cx43. A faint band of the expected size (È43 kDa) was detected in most of the cell
lines. No signal was observed for No. 1051. Total mouse brain was used as a positive control and A-actin as a loading control. For
this experiment, 30 Kg of protein was loaded in each lane. Lower panel: The Cx43 signal was normalized to A-actin intensity. An
average of 3 independent experiments is shown. Error bars represent SEM. (C) Surface plot representing the acquired pixel intensity
of cells at 1 and 10 minutes after loading with the ﬂuorescent dye Lucifer yellow in different cultures. Note that, in astrocytes (upper
panel), a second peak could be recorded after 10 minutes. For the same time interval, just a single peak could be recorded in GICs.
hActin/hTFR, human actin/human transferrin receptor.
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(51). Therefore, we imaged conﬂuent GICs at 1, 10, and
30 minutes after successful loading of single cells with
Lucifer yellow. With the exception of a single No. 10 cell,
it was not possible to detect spreading of ﬂuorescence signal
to nearby cells in any of the lines tested (No. 10, n = 7;
No. 1034, n = 8; No. 1063, n = 4; No. 1095, n = 9; No. 1051,
n = 5) (Fig. 4C), indicating low or absent junctional coupling.
GICs Have an Intermediate Membrane Resistance
and Exhibit Voltage-Dependent Outward Currents
The ensemble of ionic conductance present at the plasma
membrane confers characteristic electrophysiologic signatures
to the cells of different lineages (23). Consequently, to mea-
sure the ionic currents and functional membrane properties
of GIC, we performed whole-cell patch clamp recordings of
dissociated spheroids.
The membrane resistance of distinct CNS cellular pop-
ulations lies within a characteristic range, as reported for as-
trocytes (È10 M6), (50, 52), oligodendrocytes (G200 M6)
(24), NG2 glia (È0.2 and 1 G6) (53), and neural progenitors
of the subventricular zone (up to 4 G6) (26). When we
measured the membrane resistance of GICs, we observed an
intermediate resistance (300Y600 M6) in all lines (No. 10,
397.3 T 36.46 M6, n = 8; No. 1034, 497.0 T 158.5 M6, n = 4;
No. 1063, 631.8 T 45.9M6, n = 15; No. 1095, 401.1 T 44.24M6,
n = 8; No. 1051, 331.7 T 39.75 M6, n = 10) (Table).
The complex arrangement of voltage-dependent ion
channels provides the membrane of distinct cell lineages with
TABLE. Membrane Properties and Differentiation Potential of Glioma-Initiating Cells
Cell Line No. 10 No. 1034 No. 1063 No. 1095 No. 1051
Rm, M6 397.3 T 36, n = 8 497.0 T 158, n = 4 631.8 T 46, n = 15 401.1 T 44, n = 8 331.7 T 40, n = 10
IA
Time to peak, milliseconds 2.6 T 0.6, n = 11 1.6 T 0.2, n = 9 1.9 T 0.4, n = 9 1.5 T 0.1, n = 17 2.2 T 0.6, n = 8
TFast, milliseconds 9.8 T 3.6, n = 18 7.2 T 1.4, n = 11 9.2 T 3, n = 10 7.1 T 1.8, n = 8 9.9 T 3.8, n = 5
TSlow, milliseconds 58.0 T 18, n = 17 81.2 T 25, n = 11 49.7 T 7, n = 10 200.2 T 103, n = 8 99.7 T 53.4, n = 6
IA 100 mV, pA/pF 14.3 T 2.8, n = 24 122.9 T 55.1, n = 10 15.23 T 7.1, n = 9 31.35 T 9.6, n = 9 2.3 T 0.8, n = 6
Activation Vhalf, mV j32.9 T 4.2, n = 10 j37.6 T 1.7, n = 9 j25.7 T 6.0, n = 6 j42.8 T 4.7, n = 13 j28.3 T 8.6, n = 5
Inactivation Vhalf, mV j15.9 T 2.2, n = 7 j11.2 T 2.6, n = 7 j18.9 T 5.5, n = 3 j10.1 T 1.6, n = 6 j19.5 T 2.1, n = 4
IDR
IDR 40 mV, pA/pF 45.2 T 3.8, n = 46 39.5 T 6.4, n = 18 17.7 T 4.9, n = 25 6.0 T 1.0, n = 35 8.4 T 1.3, n = 28
Activation Vhalf, mV j13.7 T 1.7, n = 24 j13.8 T 1.5, n = 11 j13.9 T 2.4, n = 14 j9.6 T 1.8, n = 8 j14.3 T 1.6, n = 17
IDR 40 mV TEA block, % 70.0 T 7.4, n = 6 78.5 T 6.5, n = 6 64.0 T 4.8, n = 6 86.1 T 4.7, n = 7 76.4 T 5.6, n = 10
Rectifying cells 40/40 15/15 13/22 6/17 18/19
INa+
INa+ -20 mV, pA/pF 8.7 T 1.0, n = 53 6.5 T 0.8, n = 19 5.1 T 1.1, n = 18 6.9 T 0.9, n = 35 2.9 T 0.6, n = 10
Activation Vhalf, mV j24.5 T 1.2, n = 11 j26.5 T 2.0, n = 12 j27.9 T 2.0, n = 12 j28.4 T 1.6, n = 19 j22.6 T 8.5, n = 4
Voltage transient
Expressing cells 5/18 5/5 7/19 9/26 3/8
MRR, mV per millisecond 8.2 T 1.0, n = 5 15.7 T 2.6, n = 5 13.7 T 2.6, n = 7 20.3 T 4.3, n = 7 5.0 T 1.1, n = 3
MRF, mV per millisecond j2.5 T 0.4, n = 5 j6.2 T 2.8, n = 5 j5.8 T 1.7, n = 7 j4.7 T 0.9, n = 7 j1.7 T 0.2, n = 3
Width, milliseconds 16.5 T 2.9, n = 5 7.2 T 1.6, n = 5 11.3 T 2.7, n = 7 18. 6 T 8.9, n = 7 31.5 T 10.2, n = 3
AHP, mV j1.3 T 1.3, n = 5 j7.0 T 3.9, n = 5 j4.9 T 2.3, n = 7 j8.9 T 3.4, n = 7 j2.2 T 2.1, n = 3
Overshoot, mV 10.2 T 1.8, n = 5 16.0 T 3.3, n = 5 7.2 T 3.5, n = 7 20.3 T 8.8, n = 7 8.0 T 0.1, n = 3
IAMPA
IAMPA-80 mV, pA/pF j2.5 T 0.9, n = 15 j1.1 T 0.3, n = 11 0.5 T 0.1, n = 7 j0.7 T 0.2, n = 7 j1.2 T 0.3, n = 9
CTZ-IAMPA (fold increase) 19.3 T 4.1, n = 15 20.9 T 5.5, n = 11 11.9 T 9.0, n = 7 6.3 T 1.7, n = 7 7.2 T 1.3, n = 9
Differentiation
GFAP-positive cells, %
Neurobasal (control) 41 30 0 0 0
mSATO 48 32 8 71 2
FCS 92 63 62 16 23
CNTF 53 80 79 92 2
Forskolin 70 65 97 94 0
ELAVL2-4Ypositive cells, %
Growth factor removal 0 0 0 2 3
Forskolin 0 0 0 5 4
Dye coupling 1/7 0/8 0/4 0/9 0/5
Unless otherwise stated, values represent mean T SEM.
AHP, relative after hyperpolarization; CNTF, ciliary neurotrophic factor; FCS, fetal calf serum; GFAP, glial ﬁbrillary acidic protein; MRF, maximum rate of fall; MRR, maximum
rate of rise; mSATO, modiﬁed SATO medium; TEA, tetraethylammonium chloride.
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characteristic responses to voltage stimuli (23). Thus, by ap-
plying depolarizing steps from j20 and up to 100 mV for
250 milliseconds from a holding potential of j80 mV, we
recorded a complex current characterized by transient in-
ward and outward voltage-dependent components. The out-
ward current was present in all cells studied and could
be dissected into an inactivating (IA) and a sustained (IDR)
component (Fig. 5A).
Sustained component IDR was isolated by applying a
200-millisecond prepulse to j20 mV that inactivated IA. To
study the biophysical parameters of IA, it was isolated by
digitally subtracting IDR from the total outward current elicited
when the prepulse was held atj80 mV (Fig. 5A). Inactivating
component IA had a fast rising phase, with a similar time to
peak in all cell lines (È2 milliseconds; p = 0.21) and a double
exponential decay with fast (8.6 T 0.6 milliseconds) and slow
(97.7 T 27.1 milliseconds) components. No signiﬁcant dif-
ferences were found in their inactivation time constants (fast,
p = 0.96; slow, p = 0.14) (Table).
Most cells in all lines tested expressed IA as follows:
24 of 32 cells in No. 10; 19 of 20 in No. 1034; 11 of 17 in
No. 1063; 26 of 28 in No. 1095; and 16 of 24 cells in No.
1051. A signiﬁcant variation was observed in the IA density
(p = 0.003), where the values ranged from 2.3 T 0.8 pA/pF in
No. 1051 (n = 6) to 122.9 T 55.1 pA/pF in No. 1034 (n = 10).
Despite the differences in its density, the voltage dependence
of the current showed no signiﬁcant differences between lines,
as evidenced by a current to voltage (IYV) relationship with a
global mean half activation of j33.5 T 3.1 mV (p = 0.11) and
a global mean half inactivation of j74.5 T 1.5 mV (p = 0.13)
(Fig. 5B, C).
As for IA, variations in the average steady state IDR
density were measured across cell lines. It was possible to
identify lines with a higher overall IDR density: No. 10, 45.2 T
3.8 pA/pF (n = 46); No. 1034, 39.5 T 6.4 pA7/pF (n = 18);
No. 1063, 17.7 T 4.9 pA/pF (n = 25); and others with lower
values: No. 1051, 8.4 T 1.3 pA/pF (n = 28) and No. 1095,
6.0 T 1.0 pA/pF (n = 35) (Fig. 6B). In addition, IDR was
FIGURE 5. Voltage-dependent currents in glioma-initiating cells (GICs). (A) Representative current of a No. 1095 cell in response to
a voltage stimulation protocol (Ai, inset) with fast inward and outward components (Ai). The outward current could be dissected
into 2 components, that is, sustained IDR (Aii) and inactivating (IA) (Aiii). For IDR, a -20 mV prepulse was applied (Aii, inset). IA was
isolated by subtracting IDR from the total current (Aiii, inset). (B) IYV relationship of IA. No signiﬁcant differences were found in the
mean activation time constants of IA. Error bars represent SEM. (C) Peak current normalized to peak at 100 mV (Ci, top panel)
against prepulse potential (Ci, bottom panel) of IA is used to plot the voltage-dependent inactivation of IA (Cii). Data points are
mean I/Imax values T SEM. Continuous lines represent a ﬁt to the data.
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FIGURE 6. Properties of sustained current (IDR) in glioma-initiating cells (GICs). (A) Representative current traces of a No. 10 cell
(upper panel) in response to variable voltage stimuli (lower panel). The steady state current is larger at 40 mV than at 100 mV
(arrows). (B) IDR density at 40 mV of individual cells for all cell lines tested. Each point represents a single cell. Red lines represent the
mean value. (C) Ten millimolar tetraethylammonium chloride (TEA) blocked IDR elicited by a voltage pulse to 40 mV (inset) to
approximately 70%. (D) IYV relationship of IDR in all cell lines. Continuous lines represent a ﬁt to the data. Mean T SEM. (E)
Percentage of cells with and without rectiﬁcation across lines. (F) Signiﬁcant differences in IDR density at 40 mV in No. 1063 and No.
1095 between cells with (white) and without (black) rectiﬁcation. (G) Normalized IYV relationship of No. 10 cells in the presence
(solid circles) or absence (open circles) of intracellular magnesium. Solid lines represent a ﬁt to the data. Error bars represent SEM
and are in some cases obscured by the markers. Asterisks represent p G 0.05. (H) Kv1.5 (red) immunostaining in GICs showing
marked membrane pattern in all cells. Cell nuclei were counterstained with TO-PRO-3 (TP3, blue). Scale bar = 20 Km.
FIGURE 7. Fast transient inward currents are blocked by tetrodotoxin (TTX) and have similar voltage dependence across lines. (A)
Complex current of a No. 1095 cell (upper panel, same as in Fig. 5) in response to a voltage protocol (lower panel). In the ﬁrst 10
milliseconds, a transient inward current can be observed (*, inset). (B) Current density was similar across cell lines (Bii) as deter-
mined by the peak current at 0 mV (Bi). (C) Current traces of a single cell in standard extracellular solution (upper row), on
application of 500 nmol/L TTX (middle row), and after washing (lower row). The red trace corresponds to the stimulation voltage.
(D) I-V relationship of the inward current (mean T SEM); continuous lines represent a ﬁt to the data.
J Neuropathol Exp Neurol  Volume 72, Number 4, April 2013 Electrophysiologic Properties of Glioma-Initiating Cells
 2013 American Association of Neuropathologists, Inc. 317
Copyright © 2013 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.
Barrantes-Freer et al J Neuropathol Exp Neurol  Volume 72, Number 4, April 2013
 2013 American Association of Neuropathologists, Inc.318
Copyright © 2013 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.
reversibly and partially blocked (È70%) by 10 mmol/L TEA
in all cell lines tested (No. 10, n = 6; No. 1034, n = 6; No. 1063,
n = 4; No. 1095, n = 7; No. 1051, n = 10), compatible with a
current mediated by voltage-gated K+ channels (Fig. 6C).
Despite their differences in current density, the IYV re-
lationship of IDR revealed a similar half activation potential
(approximately j13 mV) for all cell lines (p = 0.58). More-
over, a rectiﬁcation of the current at approximately 40 mV
was also observed in all groups (Fig. 6D). The rectiﬁcation
was present in more than 95% of the cells in No. 10 (100%,
n = 40), No. 1034 (100%, n = 15), and No. 1051 (95%, 18 of
19 cells). For cell lines 1063 and 1095, the percentage of
positive cells was approximately 60% (n = 22 and n = 17,
respectively) (Fig. 6E). Cells that did show rectiﬁcation had
a signiﬁcantly larger current density that, on average, was
3 to 6 times larger than that of cells without rectiﬁcation
(No. 1063, p = 0.01; No. 1095, p = 0.04), suggesting that the
phenomenon was related to current magnitude (Fig. 6F). In
addition, we explored the effect of intracellular Mg2+ on IDR
rectiﬁcation using No. 10 as a representative cell line. We
observed that removal of Mg2+ from the intracellular solu-
tion abolished the rectiﬁcation (n = 6), suggesting an Mg2+-
dependent mechanism (Fig. 6G). This observation prompted
us to test the expression of Kv1.5, a delayed rectiﬁer potas-
sium channel that is ubiquitously expressed in OPCs and that
exhibits Mg2+-dependent rectiﬁcation; it might, therefore,
correspond to the major contributor of IDR in normal OPCs
(54). By immunocytochemistry, we could observe an abun-
dant expression of Kv1.5 in the cell membrane of GICs in all
lines (Fig. 6H).
Voltage-Dependent Na+ Currents and
Regenerative Voltage Transients
Besides the described currents, the electrophysiologic
proﬁle of glioma cells was characterized by a fast transient
inward current within the ﬁrst 2 milliseconds of a depolarizing
pulse betweenj40 and 40mV (Fig. 7A). In all cases (n = 4Y7),
more than 95% of the current was reversibly blocked by
500 nmol/L TTX (Fig. 7C). The IYV relationship showed no
signiﬁcant differences in half-maximal activation (j30 to
j26 mV, p = 0.59) or reversal potential (È50 mV, p = 0.68)
(No. 10, n = 11; No. 1034, n = 12; No. 1063, n = 11; No.
1095, n = 19; No. 1051, n = 4) (Fig. 7D) (Table). The kinetic
and pharmacologic characteristics indicate that voltage-
gated Na+ channels mediate the inward current. The density
of INa atj20 mV ranged from 1.4 T 0.5 pA/pF in No. 1051 to
8.7 T 0.9 pA/pF in No. 10 and signiﬁcantly varied among
lines (p G 0.001) (Fig. 7B). Voltage-gated Na+ channel cur-
rents were found in most cells within a line as follows: No. 10,
98% positive cells (n = 54); No. 1034, 100% (n = 23); No.
1063, 82% (n = 22); and No. 1095, 97% (n = 37), with the
exception of No. 1051, where only 10 of 30 cells expressed
INa. To quantify the percentage of cells expressing sodium
channels, we stained the cells with a pan-sodium channel
antibody. The labeling showed a signal cluster adjacent to the
nucleus and, in some cases, a peripheral pattern suggestive
of membrane localization. The proportion of positive cells
was similar to that found by electrophysiology in most cases:
No. 10, 96%; No. 1034, 93%; No. 1063, 76%. For the re-
maining 2 cell lines, both methods gave different results,
where No. 1095 showed less (56%) and No. 1051 more (72%)
positive cells than by electrophysiology (W2 = 19.94, p =
0.0005). This might reﬂect a difference in the sensitivity of the
2 methods because immunocytochemistry detects channels in
both the intracellular and membrane compartments, whereas
electrophysiology can only detect membrane-resident func-
tional channels.
The expression of voltage-gated Na+ channels in glioma
cells, astrocytes, and NG2 glia has been reported to provide
cells with the ability to produce voltage spikes (23, 28, 30).
After conﬁrming the expression of voltage-gated Na+ chan-
nels in GICs, we tested the excitability of the cell membrane
by measuring the voltage response to variable current in-
jections. On current stimulation approximately 50 pA, all No.
1034 cells (n = 5) or approximately one third of the cells in
other lines (No. 10, 5 of 18 cells; No. 1063, 7 of 19 cells; No.
1095, 9 of 26 cells; No. 1051, 3 of 8 cells) produced a single
regenerative voltage transient (Fig. 8A). The transient was
broad, with a similar width at baseline for all cell lines (range,
7.24Y31.5 milliseconds; p = 0.17), and slow, with a peak max-
imum rate of rise (MRR) of 20.26 T 4.3 mV per millisecond
in No. 1095 (n = 7) and a peak maximum rate of fall (MRF)
of j6.2 T 2.8 mV per millisecond in No. 1034 (n = 5), not
signiﬁcantly different between cell lines (MRR, p = 0.06;
MRF, p = 0.32) (Fig. 8B; Table). Cells in which transients
could be elicited had a signiﬁcantly larger INa density in No.
1095, p = 0.002, and No. 1051, p = 0.04. In the remaining
cell lines, a similar tendency was observed, although no sig-
niﬁcance was reached. Voltage transients were completely
abolished when 500 nmol/L TTX was applied to the extra-
cellular solution (n = 7) (Fig. 8B). A comparison of the shape
and amplitude of the transients between cell lines is depicted
in Figure 8C and the Table.
Functional AMPA Glutamate Receptors in GICs
Glutamate receptors of the AMPA type have been ex-
tensively studied in distinct populations of the normal CNS,
particularly in the context of synaptic coupling between neu-
rons and NG2 glia/astrocytes (24, 50, 55, 56), as well as in
gliomas (57). To test whether GICs express functional gluta-
mate receptors, we recorded the current response at j80 mV
on application of 150 Kmol/L AMPA. In all cells tested (No. 10,
FIGURE 8. Voltage transients in glioma-initiating cells (GICs). (A) Voltage response to a stepwise current injection protocol (inset)
characterized by a single regenerative voltage transient. (B) The ﬁrst derivative of the voltage (Bii) showed no signiﬁcant differences
in the mean maximum rate of rise and maximum rate of fall (Biii) (one-way ANOVA). The transient was abolished on the application
of tetrodotoxin (TTX) (Bi). (C) Representative voltage trace from a No. 1034 cell (same as in [A], [B]) showing a schematic
representation of the reference points used to measure different biophysical parameters (Ci). The mean values for absolute re-
generative transient peak (Cii), relative overshoot (Ciii), relative afterhyperpolarization (AHP) (Civ), and transient width (Cv) are
represented for each cell line. Error bars represent SEM. * p G 0.05.
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n = 15; No. 1063, n = 7; No. 1095, n = 7; No. 1051, n = 9; and
No. 1034, n = 11), we measured an inward current with an
average density between 0.5 T 0.12 pA/pF in No. 1063 and
2.5 T 0.9 pA/pF in No. 10 (Fig. 9A, B). The current had
a mean reversal potential of 2.6 T 3 mV for all lines. After a
4-second application of 100 Kmol/L CTZ, a positive allosteric
modulator of glutamate receptors of the AMPA type (58), we
observed a signiﬁcant 6- to 20-fold increase in the current
elicited by AMPA in all cell lines (No. 10, p G 0.0001, n = 15;
No. 1063, p = 0.015, n = 7; No. 1095, p = 0.03, n = 7; No. 1051,
p = 0.003, n = 9; No. 1034, p = 0.001, n = 11) (Fig. 9A, B),
suggesting that the current was mediated by glutamate
receptors of the AMPA type. In addition, we could conﬁrm
the presence of GluR1 by immunostaining (Fig. 9C).
Differentiation Is Accompanied by Changes in
the Electrophysiologic Proﬁle of GICs
The membrane properties of GICs resemble an imma-
ture phenotype. Therefore, we wanted to test whether this
electrophysiologic proﬁle was an invariable feature of GICs
irrespective of morphology and marker expression or a vari-
able trait faithfully reﬂecting maturation status.
To test these possibilities, we performed patch clamp
experiments of GICs after growth factor removal. By using a
voltage ramp from j120 to 120 mV, we observed a current
with linear voltage dependence and an overall reversal po-
tential at j75.4 T 3 mV, which showed no signiﬁcant dif-
ferences between lines (Fig. 10A). Furthermore, by increasing
the extracellular K+ concentration from 2.5 to 130 mmol/L, a
reversible and signiﬁcant change in the global mean reversal
potential to 4.9 T 0.8 mV could be observed (Fig. 10B),
suggesting K+ conductance. In this conﬁguration, the inward
current had a mean magnitude at j80 mV of j9.1 T 1.8 nA
for all lines. The inward component could be reversibly
blocked (È60%) by the application of 10 Kmol/L Ba2+ to the
extracellular solution (Fig. 10C, D).
DISCUSSION
In this study, we addressed the question of the iden-
tity of human GICs using a combination approach based on
marker expression, differentiation potential, and functional
membrane properties. We show that, besides the expression of
NSC and progenitor cell markers, human GICs show restricted
FIGURE 9. >-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in glioma-initiating cells. (A) An inward
current was elicited on application of AMPA (left, upper panel) and further potentiated by cyclothiazide (CTZ) (left, lower panel).
The current reverted close to 0 mV (right). (B) CTZ produced an increment in the AMPA currents in all cell lines (one-way ANOVA
with Dunnet test). Error bars represent SEM. * p G 0.05; ** p G 0.01; *** p G 0.001. (C) Immunostaining of GluR1 (green) showing a
punctate signal in all cells. Note that neuronal cultures from primary hippocampal cultures (lowermost panel, right) show het-
erogeneous staining. Nuclei were stained with TOPRO-3 (blue). Scale bar = 20 Km.
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differentiation potential and characteristic electrophysiologic
properties of an immature phenotype. Furthermore, we dem-
onstrate that the membrane properties of GICs reﬂect their
differentiation status.
In agreement with previous reports, the cells used in
this study expressed markers of neural stem and progenitors
cells (10). Notably, we observed coexpression of NG2 and
PDGFR->, both distinctive markers of NG2 glia (47). Other
groups have also reported that NG2-positive/PDGFR->Y
positive cells constitute most of the NG2-positive populations
in human GBM (14). The antigenic proﬁle is suggestive of
an OPC lineage; however, GICs in our series also expressed
nestin and GFAP and hence cannot be classiﬁed as NG2 glia
based solely on this criterion. First, NG2 glia do not express
GFAP under normal conditions (59, 60). Also, a thorough
marker analysis of the mouse SVZ did not ﬁnd NG2 expression
in neural progenitors (60); however, the expression of nestin
has been reported in NG2 glia dissociated from the normal
brain (59). In addition, the coexpression of nestin and NG2 has
been reported in GBM, suggesting that the coexpression of
FIGURE 10. Changes in the electrophysiologic properties of glioma-initiating cells on differentiation. (A) Representative current
trace of a No. 1034 cell in response to a voltage ramp fromj120 to 120 mV with 2.5 mmol/L (red) or 130 mmol/L (black) K+ in the
extracellular solution. (B) The change in K+ concentration produced a signiﬁcant change in the reversal potential in all cell lines. (C)
Representative trace of a No. 1095 cell at 130 mmol/L extracellular K+ before (red) and after (black) the application of 10 Kmol/L
Ba2+ in the bath solution. (D) No signiﬁcant differences in the percentage of Ba2+ block of the inward component of the current
shown in (A) across cell lines. Bars represent mean values T SEM.
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these 2 markers might be a particular trait of glioma cells (13).
Alternatively, it has been proposed that the expression of NG2
in GBM is the result of environmental selective pressure and
carries no relationship with lineage (22).
Another argument that speaks against a pure OPC
identity of GICs is their limited differentiation potential. The
characteristic bipotential (oligo-astroglial) differentiation of
OPCs observed in vitro on addition of FCS (61) was not
recapitulated by GICs. Contrary to the response of con-
trol mouse OPCs (Figure, Supplemental Digital Content 3,
http://links.lww.com/NEN/A438, shows O4 and MBP expres-
sion in OPCs after differentiation with mSATO), we could
not observe the expression of early (O4) or late (MBP) oli-
godendroglial markers in GICs after several differentiation
regimens. Nevertheless, in agreement with other studies, GICs
did respond to most of the differentiation stimuli by increas-
ing their GFAP expression and with characteristic morpho-
logic changes, suggesting conserved differentiation ability of
an astroglial-like lineage. Moreover, the preferential astroglial
commitment is supported by the electrophysiologic changes
observed during differentiation, namely, increase in K+ con-
ductance, linearization of the current-voltage relationship, and
expression of Ba2+-sensitive inward currentsVall character-
istic features of mature astrocytes (62).
The expression of early, but not late, markers of neu-
ronal lineage in a few cells in just 2 lines suggests that some
cells might retain the ability for multipotential differentiation.
Together with the irregular GFAP expression in undiffer-
entiated cells, this illustrates the heterogeneous nature de-
scribed for GICs both between and within cultures, which
might, in turn, reﬂect the phenotypic diversity of GBM. The
question of the individual contribution of each individual
population to tumor formation remains unresolved and lies
out of the scope of this study.
Although incompatible with a pure OPC or NSC phe-
notype, the limited differentiation potential of GICs is in
agreement with the antigenic properties of GBMs, which
typically express GFAP and rarely express markers of mature
neurons or oligodendrocytes (13).
The undetectable dye coupling (except for 1 cell in line
10) suggests reduced or absent gap junctional communication
of GICs, in contrast to mature oligodendrocytes and astro-
cytes. However, these results must be interpreted cautiously
because the characteristics of the intercellular communica-
tion in a laminar arrangement might differ from those of
GIC spheroids. Also, the preparation used might lead to an
underestimation of the number of cells between which dye
spreading does occur particularly if the cultures retain some
spheroid-like growth pattern. Nevertheless, the low RNA ex-
pression levels of the principal oligo- and astroglial connexins
in GICs support the data from dye coupling experiments and
suggest overall reduced gap junctional communication.
Most CNS lineages have a well-characterized robust
electrophysiologic signature (23, 25). Therefore, to obtain
further quantitative evidence about the identity of GICs, we
measured their membrane properties using patch clamp to
characterize several membrane parameters at a functional
level simultaneously in real time. We determined that GICs
have a membrane resistance consistent with that reported for
normal NG2 glia (53) and 2- to 30-fold larger than that
reported for astrocytes and oligodendrocytes (50). Because
the membrane resistance was in all cases between 300 and
600 M6, the signiﬁcant differences observed probably reﬂect
smaller variations in the ion channel composition of the distinct
GIC lines rather than a major difference in the cell lineage.
The low membrane resistance of normal astrocytes and
oligodendrocytes might be caused by the presence of K+ leak
channels and gap junctional communication, which may ac-
count for the linear IYV relationships observed in voltage
clamp experiments (24, 25). In contrast, GIC currents were
characterized by strong voltage dependence and no dye cou-
pling. The outward IDR and IA have been described in sev-
eral cell lineages. For example, IA and IDR are present in NG2
glia and astrocytes (63). In NSCs, IDR is widely expressed,
and IA has been reported by 1 group (27) but 2 other groups
did not detect this current in SVZ cells (26, 64). Although IA
was a prominent feature of GICs, its density was variable
across groups.
In contrast to IA, IDR expression was ubiquitous, al-
though with variable characteristics regarding rectiﬁcation
and current density between lines. The voltage dependence of
the rectifying IDR and IA suggests that the underlying ion
channels share similar physiologic properties, but the pres-
ence of cells without rectiﬁcation opens up the possibility that
the molecular correlate of IDR is distinct, implying heteroge-
neity. At current densities of 4 to 6 pA/pF, changes as small as
1 to 2 pA/pF between a 100- and a 40-mV pulse might, in this
context, produce a reclassiﬁcation of a particular cell. There-
fore, the claim that rectifying and nonrectifying cells corre-
spond to essentially different cell types might be premature.
Furthermore, the intracellular Mg2+ dependence of rec-
tiﬁcation, together with an ubiquitous Kv1.5 membrane ex-
pression, indicates low molecular heterogeneity of the IDR
correlate in GICs, analogously to normal NG2 glia, where the
major molecular correlate of IDR is Kv1.5 (54), which exhibits
Mg2+-dependent rectiﬁcation (65).
Differences in current densities across lines were ap-
parently consistent and proportional, irrespective of current
type (IDR, INa, IAMPA). Conversely, other functional properties
such as voltage dependence, blocker/modulator sensitivity,
and biophysical properties of voltage transients were not sig-
niﬁcantly different between groups. These considerations sug-
gest that the membrane of GICs may have a similar global
ion channel composition, which might differ in the overall
amount or conductance of the channels, depending on the
particular culture.
Whether the current density reﬂects other biologic prop-
erties of GICs can be inferred from the dissimilar responses
observed in the differentiation assays. Cells with overall lower
current densities (No. 1095 and No. 1051) had concomi-
tantly lower numbers of GFAP-positive cells in control con-
ditions, were less responsive to differentiation with FCS, and
produced few ELAVL2-4Ypositive cells. These features con-
trasted with those of cell lines with high current densities,
such as No. 10 and No. 1034, whereas No. 1063 exhibited
intermediate behavior.
In addition to the previously mentioned interculture
variations, differences within cell lines were also observed.
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Notably, IA could not be detected in approximately 20% and
INa in approximately 40% of the cells. Furthermore, for any
given line, variations in the current magnitudes of IDR, IAMPA,
and INa were also detected. In normal neural progenitors, NG2
glia, and oligodendrocytes, changes in current density of INa,
IDR, and IA have been associated with differentiation status.
For example, in neural progenitors and NG2 glia, INa and IA
inversely correlate with cell maturity (27, 66). The coexis-
tence of GICs of distinct differentiation states within the same
culture is in line with the current knowledge of the biology of
GICs. Furthermore, this opens up the possibility that the
electrophysiologic proﬁle could offer a sensitive method to
detect maturational changes for which other markers are not
yet available (67). However, other confounding factors such
as cell cycleYrelated changes of channel expression (28) or
genetic aberrations might as well account for the heteroge-
neity of the currents.
Nevertheless, the changes in the electrophysiologic
proﬁle of GICs observed on growth factor removal support
the notion that the maturation status might underlie the
electrophysiologic heterogeneity of glioma cells. Moreover,
this ﬁnding provides functional evidence to the widespread
morphologic/immunocytochemical observations that GICs dif-
ferentiate into astrocyte-like cells.
In this study, we also report the ability of GICs to pro-
duce regenerative voltage transients, a feature of NG2 glia
(23, 28) and astrocytes (68). Furthermore, in agreement with
work on normal NG2 glia, just a fraction of GICs exhibited
voltage transients (28, 69). Alternatively and irrespective of
cell lineage, sodium spikes might represent a peculiar trait of
glioma cells (30, 70).
We also determined the functional expression of glu-
tamate receptors of the AMPA type in GICs. Although the
expression of AMPA receptors is common for astrocytes,
progenitors, and glioma cells, this observation highlights the
importance of glutamate in the context of malignant glioma
(57). In addition, the identiﬁcation of GluR1 together with
Kv1.5 as potential molecular correlates that contribute to the
macroscopic currents of GICs constitute the ﬁrst step toward
the development of GIC-speciﬁc therapies. The most promi-
nent example of the approach we propose (electrophysiologic
characterizationYchannel identiﬁcationYtherapy design) is the
work by the Sontheimer (71) who identiﬁed overexpression of
CLC-3 on the membrane of glioma cells. Speciﬁc blockade
of this channel by a scorpion toxin (chlorotoxin) reduced
migration and proliferation of glioma cells and has progressed
to clinical trials. Even when a single surface antigen does not
sufﬁce to identify a speciﬁc cell population, antigen combi-
nations can serve as a target with the use, for example, of
multispeciﬁc antibodies, such as triple bodies (72).
In this study, we provide quantitative evidence about
the functional membrane properties of GICs. By performing
whole-cell patch clamp recordings, we demonstrate that dis-
sociated glioma spheroids derived from 5 different human
GBMs show a common electrophysiologic phenotype. Fur-
thermore, we show that variations in the electrophysiologic
proﬁle reﬂect the maturational status of GICs. Our results
strongly suggest that human GICs are neither oligo- nor neuro-
nal precursors but represent a unique type of cells reminiscent of
an immature phenotype that most resembles but is not iden-
tical to NG2 glia in its marker expression and functional
membrane properties.
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